| NRX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US6294442099 / A4091K |
| B1Q (Frankfurt) / NRXP (NASDAQ) |
| FRA:B1Q, ETR:B1Q, B1Q:GR, NASDAQ:NRXP |
| - |
| https://www.nrxpharma.com.. |
|
NRX Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing innovative therapies for patients with potentially life-threatening conditions. With a focus on mental health, the compa..
>Volltext.. |
| 51.93 Mio. EUR |
| 54.75 Mio. EUR |
| 0.21 Mio. EUR |
| -13.3 Mio. EUR |
| -33.34 Mio. EUR |
| -2.06 EUR |
| 9.12 Mio. EUR |
| 6.29 Mio. EUR |
| -10.39 Mio. EUR |
| 0.18 |
| - |
| -86.76% |
| - |
| - |
| - |
| - |
| NRX PHARMACEUTICALS, NRX PHARMA, NRX PHARMACEUTICAL |
| 16.03.26 |
|